The AS form of FIR has been reported in cancers with high levels of c-Myc, such as in colorectal cancer, [10] hepatocellular carcinoma, [13] nonsmall lung cancer, [14] and T-cell acute lymphoblastic leukemia [21]. This evidence concerns the gene MYC and hepatocellular carcinoma.